Our results indicated that 244-MPT effectively attenuated the phosphorylation of Akt and ERK1/2 in both wildtype and T790M mutant lung cancer cells and also reduced their viability and increased apoptosis compared with the traditional TKI, gefitinib (Figures 3, 4). This evidence concerns the gene MAPK3 and lung carcinoma.